|
|
Binance |
|
|
Coinbase |
|
|
KUCOIN |
|
|
AscendEX (Formally BitMax) |
By Trader Edge at 2026-07-23 14:19
Sentiment: Negative
TLDR Eli Lilly will file for FDA approval of retatrutide in Q1 2027, delayed from its original 2025 target In Phase 3 trials, patients with obesity and Type 2 diabetes lost an average of 20.8% body weight (nearly 50 lbs) at 80 weeks Patients with obesity and cardiovascular disease lost an average of 22.6% body [...] The post LLY Stock Up 2%: Is Eli Lilly’s Retatrutide the Next Big Weight-Loss Drug? appeared first on CoinCentral. Continue reading...
Categories: Stocks
Tags: #Stocks
Source Coin Central